Close

Analyst Ratings for Mirati Therapeutics (MRTX) [Buys]

MRTX Rating Summary

MRTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MRTX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $58.36 (-0.6%) * Over Last 12-Mos
Rating Score: 3.1 / 10   Percentile Rank: 27%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/25/2023 Oppenheimer
» Updated 8/9/2023
Jay Olson Upgrade Outperform
(Perform)
62.00
(56.00)
43.84
(58.70)
33.9% Details
5/20/2022 Guggenheim Michael Schmidt Upgrade Buy
(Neutral)
115.00
(N/A)
59.61
(58.70)
-1.53% Details
Like MRTX Ratings? Also take a look at BMY, KURA, SNY, ACRS

MRTX Ratings News